Chemoinformaics analysis of 1-Allyl-2,4-Dimethoxybenzene
| Molecular Weight | 178.231 | nRot | 4 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 7 |
| Exact Molecular Weight | 178.099 | nRing | 1 |
| Solubility: LogS | -3.26 | nHRing | 0 |
| Solubility: LogP | 3.023 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 29.3091 |
| nHD | 0 | BPOL | 17.5169 |
| QED | 0.659 |
| Synth | 1.827 |
| Natural Product Likeliness | 0.158 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.366 |
| MDCK | 0.0000233 |
| BBB | 0.776 |
| PPB | 0.921856 |
| VDSS | 1.098 |
| FU | 0.0388062 |
| CYP1A2-inh | 0.972 |
| CYP1A2-sub | 0.958 |
| CYP2c19-inh | 0.917 |
| CYP2c19-sub | 0.878 |
| CYP2c9-inh | 0.239 |
| CYP2c9-sub | 0.894 |
| CYP2d6-inh | 0.819 |
| CYP2d6-sub | 0.944 |
| CYP3a4-inh | 0.54 |
| CYP3a4-sub | 0.458 |
| CL | 11.366 |
| T12 | 0.653 |
| hERG | 0.038 |
| Ames | 0.115 |
| ROA | 0.031 |
| SkinSen | 0.793 |
| Carcinogencity | 0.749 |
| EI | 0.974 |
| Respiratory | 0.082 |
| NR-Aromatase | 0.016 |
| Antiviral | No |
| Prediction | 0.704189 |